Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 21Breast Neoplasms 18Hematologic Neoplasms 17Colorectal Neoplasms 12Prostatic Neoplasms 11Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Hematopoietic and Lymphatic System Neoplasm 9Anatomic Stage I Breast Cancer AJCC v8 9Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Neoplasm Metastasis 6Uterine Cervical Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Multiple Myeloma 5Melanoma 5Leukemia, Myeloid, Acute 5Head and Neck Carcinoma 5Breast Carcinoma In Situ 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Hematopoietic and Lymphoid System Neoplasm 4Carcinoma, Renal Cell 4Rectal Neoplasms 3Myelodysplastic Syndromes 3Mouth Neoplasms 3Malignant Solid Neoplasm 3Lymphoma 3Head and Neck Neoplasms 3

Interventions

entecavir 10Lamivudine 5Tenofovir 4lenvatinib 2Sorafenib 2Radiofrequency Ablation 2Hepatitis B Vaccines 2tenofovir alafenamide 1polysaccharide MGN3 1peginterferon alfa-2b 1peginterferon alfa-2a 1navitoclax 1menatetrenone 1lens intermediate filament proteins 1human papillomavirus vaccine, L1 type 16, 18 1hepatitis B hyperimmune globulin 1bicyclol 1adefovir dipivoxil 1adefovir 1Urinalysis 1Ultrasonography 1Tumor Necrosis Factor-alpha 1Tetanus Toxoid 1Telbivudine 1Tablets 1Standard of Care 1Rapid Diagnostic Tests 1Raltegravir Potassium 1Radiomics 1Practice Guidelines as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis B × Practice Guidelines as Topic × Clear all
NCT03887702 2024-05-20

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

SWOG Cancer Research Network

Phase 3 Terminated
4 enrolled 5 charts

Hepatitis B

Data powered by HemOnc (CC BY 4.0) Colophon âš¡